The US has a love-hate relationship with the Indian generics industry
Last week, reports claimed that Sun Pharma, an Indian generics manufacturer, was in talks to acquire Meda AB, a Swedish pharmaceutical company for $5 billion. This week saw Meda AB denying the rumour of a takeover. If there have been discussions,…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.